The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Platelet Dysfunction in Type 2 Diabetes
Open accessAbstract
Insulin resistance is a uniform finding in type 2 diabetes, as are abnormalities in the microvascular and macrovascular circulations. These complications are associated with dysfunction of platelets and the neurovascular unit. Platelets are essential for hemostasis, and knowledge of their function is basic to understanding the pathophysiology of vascular disease in diabetes. Intact healthy vascular endothelium is central to the normal functioning of smooth muscle contractility as well as its normal interaction with platelets. What is not clear is the role of hyperglycemia in the functional and organic microvascular deficiencies and platelet hyperactivity in individuals with diabetes. The entire coagulation cascade is dysfunctional in diabetes. Increased levels of fibrinogen and plasminogen activator inhibitor 1 favor both thrombosis and defective dissolution of clots once formed. Platelets in type 2 diabetic individuals adhere to vascular endothelium and aggregate more readily than those in healthy people. Loss of sensitivity to the normal restraints exercised by prostacyclin (PGI2) and nitric oxide (NO) generated by the vascular endothelium presents as the major defect in platelet function. Insulin is a natural antagonist of platelet hyperactivity. It sensitizes the platelet to PGI2 and enhances endothelial generation of PGI2 and NO. Thus, the defects in insulin action in diabetes create a milieu of disordered platelet activity conducive to macrovascular and microvascular events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Grundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B. V., Mitch, W., Smith, S. C., & Sowers, J. R. (1999) · Circulation · doi:10.1161/01.cir.100.10.1134 · Cited by 2,698
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
All ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,799
Reaven, G. M., Lithell, H., & Landsberg, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340607 · Cited by 1,435 · cited 2×
“Hypertension is a component of the metabolic syndrome, which occurs in many patients with the lipid triad (2,3).”
BackgroundBucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Fibrinogen as a Cardiovascular Risk Factor: A Meta-Analysis and Review of the Literature
Ernst, E., & Resch, K. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-12-199306150-00008 · Cited by 990
Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation.
Shattil, S. J., Hoxie, J. A., Cunningham, M., & Brass, L. F. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39154-8 · Cited by 942
Stenberg, P. E., McEver, R. P., Shuman, M. A., Jacques, Y. V., & Bainton, D. F. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.3.880 · Cited by 871
Diabetes mellitus : a fundamental and clinical text
LeRoith, D., Taylor, S. I., & Olefsky, J. M. (2004) · Cited by 699
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome
Grundy, S. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00033-2 · Cited by 525 · cited 8×
“Hypertension is a component of the metabolic syndrome, which occurs in many patients with the lipid triad (2,3).”
BackgroundInfluentialColler, B., Peerschke, E., Scudder, L., & Sullivan, C. (1983) · Blood · doi:10.1182/blood.v61.1.99.99 · Cited by 460
Inactivation of endothelial derived relaxing factor by oxidized lipoproteins.
Chin, J. H., Azhar, S., & Hoffman, B. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115549 · Cited by 450
Relation of diabetic control to development of microvascular complications
Tchobroutsky, G. (1978) · Diabetologia · doi:10.1007/bf00421230 · Cited by 425
Förstermann, U., Mügge, A., Alheid, U., Haverich, A., & Frölich, J. C. (1988) · Circulation Research · doi:10.1161/01.res.62.2.185 · Cited by 418
Protein Kinase N (PKN) and PKN-Related Protein Rhophilin as Targets of Small GTPase Rho
Watanabe, G., Saito, Y., Madaule, P., Ishizaki, T., Fujisawa, K., Morii, N., Mukai, H., Ono, Y., Kakizuka, A., & Narumiya, S. (1996) · Science · doi:10.1126/science.271.5249.645 · Cited by 390
Increased platelet aggregation in diabetes mellitus.
Kueh, Y. K., Bc, L., Chan, L., Thai, A. C., Kw, W., Lui, K. F., & Yeo, P. P. (1982) · PubMed · Cited by 326
Mediators produced by the endothelial cell.
Gryglewski, R. J., Botting, R. M., & Vane, J. R. (1988) · Hypertension · doi:10.1161/01.hyp.12.6.530 · Cited by 324
Juhan-Vague, I., Thompson, S. G., & Jespersen, J. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.12.1865 · Cited by 322
Effect of strenuous exercise on platelet activation state and reactivity.
Kestin, A. S., Ellis, P. A., Barnard, M. R., Errichetti, A., Rosner, B. A., & Michelson, A. D. (1993) · Circulation · doi:10.1161/01.cir.88.4.1502 · Cited by 313
Increased Platelet Aggregation in Early Diabetus Mellitus
SAGEL, J., COLWELL, J. A., CROOK, L., & LAIMINS, M. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-6-733 · Cited by 308
Hypertension, Diabetes Mellitus, and Insulin Resistance The Role of Intracellular Magnesium
Paolisso, G. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(96)00342-1 · Cited by 300
Juhan-Vague, I., Roul, C., Alessi, M. C., Ardissone, J. P., Heim, M., & Vague, P. (1989) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646598 · Cited by 289
Increased platelet thromboxane synthesis in diabetes mellitus.
Halushka, P. V., Rogers, R. C., LOADHOLT, C. B., & Colwell, J. A. (1981) · PubMed · Cited by 275
Festa, A., D’Agostino, R., Mykkänen, L., Tracy, R. P., Zaccaro, D. J., Hales, C. N., & Haffner, S. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.562 · Cited by 263
Folsom, A. R., Qamhieh, H. T., Wing, R. R., Jeffery, R. W., Stinson, V. L., Kuller, L. H., & Wu, K. K. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.162 · Cited by 225
Evidence for abnormal platelet glycoprotein expression in diabetes mellitus
TSCHOEPE, D., ROESEN, P., KAUFMANN, L., SCHAUSEIL, S., KEHREL, B., OSTERMANN, H., & GRIES, F. A. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb02264.x · Cited by 217
Kaibuchi, K., Sano, K., Hoshijima, M., Takai, Y., & Nishizuka, Y. (1982) · Cell Calcium · doi:10.1016/0143-4160(82)90020-3 · Cited by 195
Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats.
Gerrard, J. M., Stuart, M. J., Rao, G. H. R., Steffes, M. W., Mauer, S. M., Brown, D. M., & White, J. (1980) · PubMed · Cited by 186
Activated phosphoinositide 3-kinase associates with membrane skeleton in thrombin-exposed platelets.
Zhang, J., Fry, M. J., Waterfield, M. D., Jaken, S., Liao, L., Fox, J. E., & Rittenhouse, S. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42888-8 · Cited by 182
Bensoussan, D., Levy-Toledano, S., Passa, P., Caen, J., & Canivet, J. (1975) · Diabetologia · doi:10.1007/bf00422396 · Cited by 171
Dermal Neurovascular Dysfunction in Type 2 Diabetes
Vinik, A. I., Erbas, T. A., Park, T. S., Stansberry, K. B., Scanelli, J. A., & Pittenger, G. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1468 · Cited by 159
Self-citationPlasma Fibrinogen: A New Factor of the Metabolic Syndrome: A population-based study
Imperatore, G., Riccardi, G., Iovine, C., Rivellese, A. A., & Vaccaro, O. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.649 · Cited by 151
Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease
Shechter, M., Merz, C. N. B., Paul-Labrador, M. J., & Kaul, S. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00545-8 · Cited by 147
Ellenberg and Rifkin's Diabetes Mellitus: Theory and Practice
Izenstein, B. Z. (1991) · JAMA · doi:10.1001/jama.1991.03460070100056 · Cited by 141
Epinephrine potentiates human platelet activation but is not an aggregating agent
Lanza, F., Beretz, A., Stierlé, A., Hanau, D., Kubina, M., & Cazenave, J. (1988) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1988.255.6.h1276 · Cited by 137
Fonseca, V. A., Reynolds, T., Hemphill, D., Randolph, C., Wall, J., Valiquett, T. R., Graveline, J. F., & Fink, L. M. (1998) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(97)00109-8 · Cited by 127
Insulin Directly Reduces Platelet Sensitivity to Aggregating Agents: Studies In Vitro and In Vivo
Trovati, M., Anfossi, G., Cavalot, F. L., Massucco, P., Mularoni, E., & Emanuelli, G. (1988) · Diabetes · doi:10.2337/diab.37.6.780 · Cited by 125
Byberg, L., Siegbahn, A., Berglund, L., McKeigue, P., Reneland, R., & Lithell, H. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.2.258 · Cited by 113
Anfossi, G., Mularoni, E., Burzacca, S., Ponziani, M. C., Massucco, P., Mattiello, L., Cavalot, F. L., & Trovati, M. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.121 · Cited by 107
Impaired Insulin-Induced Platelet Antiaggregating Effect in Obesity and In obese NIDDM Patients
Trovati, M., Mularoni, E., Burzacca, S., Ponziani, M. C., Massucco, P., Mattiello, L., Piretto, V., Cavalot, F. L., & Anfossi, G. (1995) · Diabetes · doi:10.2337/diab.44.11.1318 · Cited by 107
Evidence for iNOS-dependent peroxynitrite production in diabetic platelets
Tannous, M., Rabini, R. A., Vignini, A., Moretti, N., Fumelli, P., Zielinski, B. S., Mazzanti, L., & Mutus, B. (1999) · Diabetologia · doi:10.1007/s001250051192 · Cited by 97
Winocour, P. D., Watała, C. W., & Kinglough-Rathbone, R. L. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648495 · Cited by 89
Platelets from diabetic subjects show diminished sensitivity to prostacyclin
Betteridge, D. J., Tahir, K. E. H. E., Reckless, J. P. D., & Williams, K. I. H. (1982) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1982.tb00686.x · Cited by 85
Ellenberg and Rifkin's Diabetes Mellitus: Theory and Practice
Rifkin, H., Porte, D., & Gallon, D. J. (1990) · Medical Entomology and Zoology · Cited by 85
9 Diabetes Mellitus, Vascular Disease and Thrombosis
Banga, J. D., & Sixma, J. J. (1986) · Clinics in Haematology · doi:10.1016/s0308-2261(18)30026-2 · Cited by 85
The platelet insulin receptor: Detection, partial characterization, and search for a function
Falcón, C., Pfliegler, G., Deckmyn, H., & Vermylen, J. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81000-3 · Cited by 83
Reduced Membrane Fluidity in Platelets From Diabetic Patients
Winocour, P. D., Bryszewska, M. J., Watała, C. W., Rand, M. L., Epand, R. M., Kinlough-Rathbone, R. L., Packham, M. A., & Mustard, J. F. (1990) · Diabetes · doi:10.2337/diab.39.2.241 · Cited by 79
Mechanisms of Platelet Activation and Inhibition
Ashby, B., Daniel, J. L., & Smith, J. B. (1990) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30503-3 · Cited by 79
Enhancement of Platelet Aggregation by Low-Density Lipoproteins From IDDM Patients
Watanabe, J., Wohltmann, H. J., Klein, R. L., Colwell, J. A., & Lopes-Virella, M. F. (1988) · Diabetes · doi:10.2337/diab.37.12.1652 · Cited by 76
Ishizuka, T., Itaya, S., Wada, H., Ishizawa, M., Kimura, M., Kajita, K., Kanoh, Y., Miura, A., Muto, N., & Yasuda, K. (1998) · Diabetes · doi:10.2337/diabetes.47.9.1494 · Cited by 75
The cellular ionic basis of hypertension and allied clinical conditions
Resnick, L. M. (1999) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(99)70006-x · Cited by 72
Decreased nitric oxide synthase activity in platelets from IDDM and NIDDM patients
Rabini, R. A., Staffolani, R., Fumelli, P., Mutus, B., CURATOLA, G., & Mazzanti, L. (1998) · Diabetologia · doi:10.1007/s001250050873 · Cited by 72
Jennings, P. E., McLaren, M., Scott, N., et al. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb02125.x · Cited by 72
Mayfield, R. K., Halushka, P. V., Wohltmann, H. J., Lopes-Virella, M. F., Chambers, J. K., LOADHOLT, C. B., & Colwell, J. A. (1985) · Diabetes · doi:10.2337/diab.34.11.1127 · Cited by 71
Inhibition of adenylate cyclase.
Jakobs, K. H., Aktories, K., Minuth, M., & Schultz, G. (1985) · PubMed · Cited by 66
Platelet cNOS Activity Is Reduced in Patients with IDDM and NIDDM
Bruno, G., Trucco, F., Zumpano, E., Tagliabue, M., Bisceglie, C. D., Pescarmona, G., & Martina, V. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614937 · Cited by 65
Livingstone, C., McLellan, A. R., McGregor, M.-A., Wilson, A., Wilson, A., Connell, J. M. C., SMALL, M. P., Milligan, G., Paterson, K. R., & Houslay, M. D. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(91)90050-j · Cited by 45
Jokl, R., Klein, R. L., Lopes-Virella, M. F., & Colwell, J. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.8.1150 · Cited by 40
Platelet insulin receptor determination in non-insulin dependent diabetes mellitus
Udvardy, M., Pfliegler, G., & Rák, K. (1985) · Cellular and Molecular Life Sciences · doi:10.1007/bf02004539 · Cited by 39
Sulfonylureas and platelet function
Klaff, L. J., Kernoff, L. M., Vinik, A. I., Jackson, W. P. U., & Jacobs, P. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90585-4 · Cited by 30
Self-citationAbrahm, D. R., Hollingsworth, P. J., SMITH, C. B., Jim, L. K., ZUCKER, L. B., Sobotka, P. A., & Vinik, A. I. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-4-906 · Cited by 29
Self-citationKahn, N. N., Mueller, H. S., & Sinha, A. (1991) · Circulation Research · doi:10.1161/01.res.68.1.245 · Cited by 27
Minuz, P., Lechi, C., Gaino, S., Bonapace, S., Fontana, L., Garbin, U., Paluani, F., Cominacini, L., Zatti, M., & Lechi, A. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649899 · Cited by 22
Kahn, N. N., Najeeb, M. S., Ishaq, M., Rahim, A., & Sinha, A. K. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90195-5 · Cited by 21
Transient Decrease of Binding of Insulin to Platelets in Acute Ischemic Heart Disease
Kahn, N. N., Bauman, W. A., & Sinha, A. K. (1994) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199401000-00004 · Cited by 17
Human prostacyclin platelet receptors in diabetes mellitus
Amedeo, M. P., Fortini, A., Gensini, G. F., Vanni, D., Prisco, D., & Abbate, R. (1991) · Thrombosis Research · doi:10.1016/0049-3848(91)90179-z · Cited by 16
Shechter, M., Merz, C. N. B., Paul-Labrador, M. J., Shah, P. K., & Kaul, S. (1999) · Cardiology · doi:10.1159/000006964 · Cited by 13
Clonidine p-isothiocyanate, an affinity label for alpha 2-adrenergic receptors on human platelets.
Atlas, D., & Steer, M. L. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.5.1378 · Cited by 11
Cited by
Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
Beckman, J. A., Creager, M. A., & Libby, P. (2002) · JAMA · doi:10.1001/jama.287.19.2570 · Cited by 2,724
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I
Creager, M. A., Lüscher, T. F., of, P. W. T. A., Cosentino, F., & Beckman, J. A. (2003) · Circulation · doi:10.1161/01.cir.0000091257.27563.32 · Cited by 1,650
Authors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
Paneni, F., Beckman, J. A., Creager, M. A., & Cosentino, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht149 · Cited by 1,401
Leon, B. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i13.1246 · Cited by 1,215
Metadata
- Authors
- Vinik, A. I., Erbas, T., Park, T. S., Nolan, R., & Pittenger, G. L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2001-08-01
- Volume
- 24
- Issue
- 8
- Pages
- 1476-1485
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2096531477
- Cited by
- 671
- References
- 72
- FWCI
- 9.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.